Ligation of TCRs on stimulated T cells leads to activation-induced cell death (AICD) resulting in the downregulation of immune responses, a process essential for T-cell homeostasis. In this study, using transformed Tcell lines such as Jurkat and Do11.10 as cellular models of TCR-mediated AICD, we have demonstrated that the proapoptotic protein Siva-1 is required for TCR-induced apoptosis. Knockdown of Siva-1 rendered T cells specifically resistant to anti-CD3 but not Fas-induced apoptosis. Further, we observed that in Siva-1 knockout Jurkat cells, TCR-mediated activation of the canonical and noncanonical limbs of the NF-jB pathway are significantly enhanced as reflected by elevated nuclear levels of p65 and RelB, respectively. In addition, loss of endogenous Siva-1 also resulted in the enhanced expression of NF-jBresponsive anti-apoptotic genes such as Bcl-xL and c-FLIP. Interestingly, the c-FLIP short was detected only in TCR-ligated Siva-1 knockdown Jurkat cells. These results demonstrate a significant role for endogenous Siva-1, through its inhibitory effect on NF-jB activity, in TCR-mediated AICD with implications in peripheral tolerance, T-cell homeostasis and cancer. Oncogene (2006 Oncogene ( ) 25, 3458-3462. doi:10.1038 published online 20 February 2006 Keywords: TCR; apoptosis; NF-kB; Bcl-xL; c-FLIP; AICD AICD is a process essential for the termination of immune responses and elimination of autoreactive T cells. Aberrant AICD can therefore result in the development of autoimmune disorders and cancers. Repetitive TCR stimulation or TCR ligation in the absence of co-stimulatory signals triggers AICD (Hildeman et al., 2002; Green et al., 2003) .
One of the essential prosurvival transcription factors that is activated upon TCR ligation is NF-kB. It consists of five members: RelA (p65), c-Rel, p105/p50, p100/p52 and RelB. Under resting conditions, NF-kB heterodimers are sequestered in the cytoplasm by IkB inhibitory proteins. T-cell activation results in the phosphorylation and degradation of IkB, leading to the translocation of p65/p50 (canonical) and p52/RelB (noncanonical) to the nucleus. They then trigger the transcription of various cell survival genes (Ghosh and Karin, 2002) . TCR ligation devoid of co-stimulatory signals, a situation that occurs during the waning phase of immune response or T-cell maturation in the thymus, results in weak activation of NF-kB (Wan and DeGregori, 2003) . Proapoptotic molecules such as Siva-1 could negatively regulate the above pathways and promote AICD.
Siva-1 was originally discovered using the cytoplasmic tail of CD27 as bait in yeast two-hybrid system. Siva-1 is the full-length predominant transcript and proapoptotic whereas Siva-2 is a minor alternate splice form that is much less toxic (Prasad et al., 1997; Yoon et al., 1999) . Despite Siva-1 lacking the typical death and Bcl-2 homology (BH) domains, it appears to promote both intrinsic and extrinsic cell death pathways (Henke et al., 2000; Cao et al., 2001; Spinicelli et al., 2002; Chu et al., 2004 Chu et al., , 2005 . Expression of Siva-1 is restricted to doublepositive thymocytes (Xue et al., 2002) , the majority of which are known to undergo negative selection (Nossal, 1994) and also in highly activated peripheral T cells targeted for AICD (supplement 1) thereby indicating a role for Siva-1 in TCR-mediated AICD.
In order to study the function of Siva-1, we abrogated its expression using the small-interfering RNA (siRNA) technology. Separate oligonucleotides specifically targeting exon 3 of either human or mouse Siva gene were cloned into pSuper (siSiva) (Brummelkamp et al., 2002) and tested initially for their efficacy in 293T cells by expressing exogenous Siva-1. Immunoblot analysis demonstrated an almost complete loss of Siva-1 expression in siSiva cells as compared to the control (Figure 1a ). Using lentiviral vector (SIN-GFP) capable of expressing siSiva or control siRNA, we achieved >80% infection in Jurkat and Do11.10 cells and obtained a substantial loss of endogenous Siva-1 expression in siSiva cells (Figure 1b) . We then used the siSiva and control Jurkat and Do11.10 cells to determine the effect of Siva-1 knockdown on TCRmediated AICD. TCR crosslinking resulted in significantly reduced apoptosis in siSiva Jurkat and Do11.10 cells as compared to their respective control siRNA cells suggesting a positive role for endogenous Siva-1 in Tcell AICD (Figure 1c and d) . This resistance to apoptosis could be reversed by expression of mouse Siva-1 (that is not targeted by human siSiva) in Jurkat siSiva cells (Figure 1e ).
We next examined the effect of Siva-1 depletion on TCR-mediated activation of NF-kB using a luciferase reporter assay. While control Jurkat cells show a timedependent increase in NF-kB activity that peaked at 5.5 h and then returned to near basal level, siSiva cells demonstrated a more robust and sustained NF-kB activation ( Figure 2a ). Similar observations were also made in Do11.10 cells (Figure 2b ). Loss of endogenous Siva-1, however, appears to have no significant effect on TCR-mediated NFAT activation ( Figure 2c ). Importantly, expression of exogenous Siva-1 had a profound inhibitory effect on both basal and TCR-induced NFkB reporter activities ( Figure 2d ). As expected, expression of mouse Siva-1 but not empty GFP vector almost completely inhibited the enhanced NF-kB activity seen in siSiva cells (Figure 2e ). The above results clearly demonstrate that the siSiva specifically targets endogenous Siva-1 and Siva-1 preferentially inhibits NF-kB activity.
We next examined IkBa degradation as a marker of endogenous NF-kB activity. TCR cross linking in Figure 1 Endogenous Siva-1 in AICD. (a) Knockdown of Siva-1 expression was performed using the pSuper-based siRNA construct (siSiva). A scrambled sequence was used as negative control (control siRNA). 293T cells were co-transfected with plasmids expressing human Siva-1 along with either siSiva or control siRNA and cell lysates were tested for efficiency of knockdown of Siva-1 expression at 60 h post-transfection by Western blot. (b) Jurkat cells stably expressing lentivirus-delivered siSiva or control siRNA were lysed and probed for endogenous Siva-1 expression. (c) Siva-1 knockdown or control Jurkat cells were stimulated with platebound anti-CD3 antibody (OKT3 (5 mg/ml)). After 24 h of stimulation, cells were treated with tetramethyl rhodamine methyl ester (TMRM) and 7-amino actinomycin (7AAD, Calbiochem). Apoptosis was determined in GFP positive and 7AAD low/ negative population by FACS (FACS Calibur, BD Biosciences). Apoptotic cells have been represented as percentage of TMRMnegative cells. Apoptosis in unstimulated control cells was taken as one and the relative fold apoptosis in all other samples of the experiment was determined. Data from four different experiments was compiled and the difference between TCR-mediated cell death in siSiva and control cells was found to be statistically significant (Po0.01). (d) Similar experiments with Do11.10 T cells using the mouse anti-CD3 antibody (2C11) also gave statistically significant results (Po0.05) further confirming a role for Siva-1 in AICD. (e) Jurkat cells were co-transfected with control siRNA or siSiva along with plasmids expressing either GFP or GFP mouse Siva-1. Anti-CD3 stimulation was performed for 24 h and apoptosis assay was done as described above. 
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control Jurkat cells did not result in any profound changes in IkBa expression. In the Siva-1 knockdown cells, however, the IkBa degradation was more robust and sustained (Figure 3a) . Following IkB degradation, NF-kB proteins translocate to the nucleus. We therefore determined the relative protein levels of p65 (canonical) and RelB (non-canonical) in matched nuclear and cytosolic extracts of Jurkat cells stably expressing either control siRNA or siSiva upon crosslinking TCRs. In control cells, as expected, we observed a time-dependent increase in p65 and RelB nuclear levels, with a corresponding decrease in the cytosolic extracts. In siSiva cells, however, the basal p65 and RelB nuclear levels were much higher and continued to remain elevated upon TCR activation. To our surprise, in these cells, we failed to detect a time-dependent depletion of cytoslic p65, and the RelB levels were barely detectable. The nuclear and cytosolic extracts were relatively pure as shown by PARP and actin levels (Figure 3b ). Based on nuclear translocation kinetics of p65 and RelB, our results clearly suggest that TCR crosslinking results in the activation of both canonical and non-canonical NFkB pathways. Whether, in the above case, non-canonical is secondary to canonical, as reported by Li et al. (2005) , Nuclear and cytosolic extracts were prepared from untreated and CD3-treated cells (Muller et al., 1989) and probed for p65 (canonical) and RelB (non-canonical) subunits using antibodies obtained from Santa Cruz. The blots were stripped and probed with anti-PARP (Cell Signaling Technologies) and anti-actin antibodies (Sigma) to demonstrate the relative purities of nuclear and cytosolic extracts, respectively. (c) TCR induced changes in p100/p52 -levels in Jurkat whole-cell lysates were monitored using anti-p52 antibody (Upstate). Actin levels were determined in parallel. Siva-1 inhibits NF-jB and promotes AICD in T cells R Gudi et al needs further investigation. Upon TCR crosslinking, p100 induction was apparent in control Jurkat cells but the levels observed in siSiva cells were significantly higher, with and without crosslinking. The fact that p52 is seen only in Siva-1 knockdown cells (in both unstimulated and stimulated) clearly indicates that Siva-1 negatively targets events upstream of IKK and NIK in NF-kB signaling pathway (Figure 3c ). Activation of NF-kB is known to induce the expression of prosurvival genes such as Bcl-xL, IEX-1 and c-FLIP (Ghosh and Karin, 2002) . Short-term activated naive T cells are known to have elevated levels of FasL and c-FLIP but do not die until they are restimulated. Upon restimulation, the c-FLIP short form degrades thereby sensitizing the cells to AICD through the Fas receptor (Schmitz et al., 2004) . We therefore examined the expression levels of Fas, FasL, c-FLIP and Bcl-xL. No significant difference in Fas and FasL surface expression levels between control and siSiva cells before and after TCR crosslinking was observed (Figure 4a ). However, immunoblotting of whole-cell lysates revealed a much higher increase in FasL expression in siSiva cells compared to controls (Figure 4b) . The above finding agrees with previously published results (Xiao et al., 2005) and substantiates our observations with respect to NF-kB activation (Figures 2 and 3) . Surprisingly, Fas-induced apoptosis in siSiva and control cells was comparable (Figure 4c ) suggesting that Siva-1 does not influence Fas-mediated cell death; however, it still has a role in TCR-mediated AICD. The levels of active caspase 3 were significantly lower in siSiva Jurkat cells after TCR stimulation, demonstrating the validity of the above experiment (Figure 4b) . Interestingly, the Bcl-xL levels were significantly higher in unstimulated siSiva cells compared to control siRNA cells and a further increase was observed upon TCR crosslinking (Figure 4d ). c-FLIPlong became apparent only after TCR crosslinking in both siSiva and control siRNA cells but was dramatically higher in siSiva cells and c-FLIP short could only be detected in activated siSiva cells (Figure 4d ). The differences in Bcl-xL and c-FLIP expression may be due to the possibility that Bcl-xL transcription is dependent mainly on NF-kB activity, whereas c-FLIP transcription may require other transcription factors triggered by TCR ligation. Our results implicate elevated levels of anti-apoptotic molecules such as Bcl-xL and c-FLIP as contributing factors for the observed resistance to TCR-mediated AICD in siSiva cells.
In summary, we find that Siva-1 negatively regulates NF-kB activity and promotes AICD thereby favoring a role for Siva-1 in T-cell homeostasis. The inhibitory role of Siva-1 on NF-kB activation is not surprising since Siva-1 is proapoptotic and also it can interact with the cytoplasmic tails of various TNFR family members (CD27, GITR, OX40 and 4-1BB) that activate NF-kB through their interaction with TRAFs (Prasad et al., 1997; Spinicelli et al., 2002) . As TRAF 2, 5, and 6 positively regulate both canonical and non-canonical pathways of NF-kB (Hauer et al., 2005) , it will be interesting to see if Siva-1 targets the TRAF proteins and promotes apoptosis. Our results demonstrate that endogenous Siva-1 inhibits both basal and TCRmediated increase in NF-kB activity. Data regarding p65 and RelB nuclear levels and NF-kB response genes ( Figures 3 and 4) clearly supports the above contention. In addition, the inhibitory effect of Siva-1 is also seen with other NF-kB stimuli such as TNFa thereby suggesting a more intrinsic role in the negative regulation of NF-kB signaling (Hawkins and Prasad, unpublished observation). The fact that Siva-1 is expressed in double-positive thymocytes and highly activated peripheral T cells support a physiological role for Siva-1 in TCR-mediated AICD through its inhibitory effect on NF-kB. Bim, a BH3-only protein plays an indispensable role in central and peripheral tolerance by promoting 'death by neglect' (Bouillet et al., 2002) . Whether, Siva-1 is required in addition to, or complements Bim is an intriguing aspect that is being investigated.
